International Stem Cell Co. (OTCMKTS:ISCO) Sees Significant Decrease in Short Interest

International Stem Cell Co. (OTCMKTS:ISCO) saw a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 300 shares, a drop of 91.4% from the November 30th total of 3,500 shares. Based on an average daily volume of 6,000 shares, the days-to-cover ratio is presently 0.1 days.

International Stem Cell Price Performance

ISCO stock traded down $0.01 during midday trading on Thursday, reaching $0.10. 2,037 shares of the company’s stock traded hands, compared to its average volume of 4,406. International Stem Cell has a fifty-two week low of $0.05 and a fifty-two week high of $0.20. The business has a 50-day moving average price of $0.09 and a two-hundred day moving average price of $0.08. The company has a market capitalization of $839,200.00, a P/E ratio of -1.31 and a beta of 0.17.

About International Stem Cell

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.